NOVATOR PHARMA LLP
Significant control: Shakhmir Iadigarov (50–75%), Aytan Yadigarova (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Novator Pharma LLP: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Novator Pharma LLP sell?
We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
NOVATOR PHARMA LLP is an active private limited company (company number OC365419) incorporated on 10 June 2011, registered in Watford. Latest small accounts cover the period ending 31 December 2024, showing net assets of £14.37m and cash of £155k, with 0 employees on average. Net assets rose 30% on the prior period (£11.08m).
Ownership and control
- Mr. Shakhmir Iadigarov
- voting rights 50 to 75 percent limited liability partnership
- right to share surplus assets 50 to 75 percent limited liability partnership
- right to appoint and remove members limited liability partnership
- Mrs. Aytan Yadigarova
- voting rights 25 to 50 percent limited liability partnership
- right to share surplus assets 25 to 50 percent limited liability partnership
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 10 June 201115 yrs ago
- Next accounts due
- 30 September 202624 days overdue
- Confirmation statement due
- 24 June 2027in 243 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC None Supplied
- None Supplied
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £14.37m | £155k | £14.22m | — | — | — | 0 |
| 31 December 2023 | £11.08m | £166k | £10.91m | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £14,372,797 at 31 December 2024
- Net assets up 10% or more on the prior period+29.8% vs prior period
- Cash at bank of £50,000 or moreCash £154,735
- Incorporated five or more years agoIncorporated 10 June 2011
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 243 days
- Next accounts due24 days overdue
- Accounts period endNet assets £14.37m · small accounts
- Accounts period endNet assets £11.08m · small accounts
- Incorporated
Reminders for NOVATOR PHARMA LLP
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.